Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc.OBIO · Entity 434 | Principal Accounting Officer | August 26, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orchestra BioMed Holdings, Inc.
Report date August 26, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 18,441 |
Reported balance
After 2026-08-26 transaction · row 1
1 source rowRow 1 · 2026-08-26 · Tax withholding · Disposed 203 · Balance 18,441 F1: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2026 Filed Aug 28, 2026 20:15 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | Tax withholdingCommon Stock, par value $0.0001 per share | 203 | $5.26 | $1,067.78 |
DisclosureSEC source: 0001104659-26-103205 · tm2624220-1_4seq1.xml · nonDerivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,441 F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations. Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 20:30 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | Tax withholdingCommon Stock, par value $0.0001 per share ("Common Stock") | 241 | $4.57 | $1,101.37 |
DisclosureSEC source: 0001104659-26-036167 · tm269936-2_4seq1.xml · nonDerivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,644 F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 22:02 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $3.82 | $0.00 |
DisclosureSEC source: 0001104659-26-015325 · tm266316-4_4seq1.xml · derivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2036-02-12 F1 · derivative.exercise_date: The stock options will vest as follows: (i) 25% of the stock options will vest on February 12, 2027 (the "Vesting Commencement Date") and (ii) the remaining 75% stock options will vest in equal installments every three months on the same day of the month as the Vesting Commencement Date, starting on May 12, 2027, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:54 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | Tax withholdingCommon Stock, par value $0.0001 per share ("Common Stock") | 241 | $4.31 | $1,038.71 |
DisclosureSEC source: 0001104659-26-000271 · tm261746-2_4seq1.xml · nonDerivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,885 F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 21:31 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | Tax withholdingCommon Stock, par value $0.0001 per share ("Common Stock") | 203 | $2.46 | $499.38 |
DisclosureSEC source: 0001104659-25-091745 · tm2526559-3_4seq1.xml · nonDerivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,126 F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 23:09 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantCommon Stock, par value $0.0001 per share ("Common Stock") | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-075779 · tm2523004-1_4seq1.xml · nonDerivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,329 F1 · kind: Represents an award of restricted stock units ("RSUs") to the Reporting Person on August 7, 2025 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after the Grant Date, (ii) 33.33% of the shares will vest 30 months after the Grant Date, and (iii) 33.34% of the shares will vest 36 months after the Grant Date, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:15 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | Tax withholdingCommon Stock, par value $0.0001 per share ("Common Stock") | 393 | $2.99 | $1,175.07 |
DisclosureSEC source: 0001104659-25-061170 · tm2518577-1_4seq1.xml · nonDerivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,329 F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations. Read SEC document |
| April 04, 2025 Filed Apr 5, 2025 01:40 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001104659-25-032332 · tm2511637-4_4seq1.xml · derivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2035-04-03 F1 · derivative.exercise_date: The stock options will vest as follows: (i) 12,000 of the stock options will vest on April 4, 2026 (the "Vesting Commencement Date") and (ii) the remaining 36,000 stock options will vest in equal installments every three months on the same day of the month as the Vesting Commencement Date, starting on July 4, 2026, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| March 26, 2025 Filed Mar 29, 2025 00:08 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | Tax withholdingCommon Stock, par value $0.0001 per share | 278 | $4.38 | $1,217.64 |
DisclosureSEC source: 0001104659-25-029494 · tm2510858-1_4seq1.xml · nonDerivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,722 F1 · kind: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations. Read SEC document |
| May 08, 2024 Filed May 10, 2024 21:24 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantStock Option (Right to Buy) · Derivative | 42,000 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001104659-24-060004 · tm2414108-6_4seq1.xml · derivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2034-05-08 F1 · derivative.exercise_date: The stock options will vest as follows: (i) 10,500 of the stock options will vest on May 8, 2025 (the "Vesting Date") and (ii) the remaining 31,500 stock options will vest in equal installments every three months on the same day of the month as the Vesting Date, starting on August 8, 2025, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| July 20, 2023 Filed Jul 24, 2023 21:10 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $7.42 | $0.00 |
DisclosureSEC source: 0001104659-23-083497 · tm2321855-4_4seq1.xml · derivative · entry 2 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2033-07-20 F2 · derivative.exercise_date: The stock options vest over a four-year period as follows: (i) 25% of the underlying shares will vest on the one-year anniversary of the grant date and (ii) 75% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting on the last day of the first quarter after the first anniversary of the grant date, or September 30, 2024, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| July 20, 2023 Filed Jul 24, 2023 21:10 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantCommon Stock, par value $0.0001 per share ("Common Stock") | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-083497 · tm2321855-4_4seq1.xml · nonDerivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of the grant date, (ii) 33% the shares will vest on the two-year anniversary of the grant date, and (iii) 33% the shares will vest on the three-year anniversary of the grant date, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:32 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantNonstatutory Stock Option (Right to Buy) · Derivative | 18,228 | Not disclosed Strike: $10.00 | Not disclosed |
DisclosureSEC source: 0001213900-23-006191 · ownership.xml · derivative · entry 5 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,228 Underlying: Common Stock · 18,228 shares Expires 2032-08-25 F9 · price: Received in the Business Combination in exchange for an incentive stock option to acquire 39,200 shares of Legacy Orchestra Common Stock for $4.65 per share. F8 · derivative.exercise_date: The incentive stock options vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the day of the month of each quarter that is the same day of the month as the grant date, starting with the corresponding date in the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:32 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantNonstatutory Stock Option (Right to Buy) · Derivative | 4,650 | Not disclosed Strike: $4.06 | Not disclosed |
DisclosureSEC source: 0001213900-23-006191 · ownership.xml · derivative · entry 4 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,650 Underlying: Common Stock · 4,650 shares Expires 2032-04-11 F7 · price: Received in the Business Combination in exchange for an incentive stock option to acquire 10,000 shares of Legacy Orchestra Common Stock for $1.89 per share. F6 · derivative.exercise_date: The incentive stock options vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis, on the day of the month of each quarter that is the same day of the month as the grant date, starting with the corresponding date in the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is April 12, 2022. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:32 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantNonstatutory Stock Option (Right to Buy) · Derivative | 4,185 | Not disclosed Strike: $4.75 | Not disclosed |
DisclosureSEC source: 0001213900-23-006191 · ownership.xml · derivative · entry 3 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,185 Underlying: Common Stock · 4,185 shares Expires 2031-08-04 F5 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 9,000 shares of Legacy Orchestra Common Stock for $2.21 per share. F4 · derivative.exercise_date: The NSOs have vested and will vest in equal installments over a three-year period on a monthly basis, on the day of the month of each month that is the same day of the month as the grant date, starting with the first month after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 5, 2021. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:32 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantNonstatutory Stock Option (Right to Buy) · Derivative | 6,975 | Not disclosed Strike: $7.66 | Not disclosed |
DisclosureSEC source: 0001213900-23-006191 · ownership.xml · derivative · entry 2 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,975 Underlying: Common Stock · 6,975 shares Expires 2030-10-13 F3 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 15,000 shares of Legacy Orchestra Common Stock for $3.56 per share. F2 · derivative.exercise_date: The nonstatutory stock options ("NSOs") have vested and will vest in equal installments over a three-year period on a monthly basis, on the day of the month of each month that is the same day of the month as the grant date, starting with the first month after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is October 14, 2020. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:32 UTC | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantNonstatutory Stock Option (Right to Buy) · Derivative | 6,975 | Not disclosed Strike: $4.30 | Not disclosed |
DisclosureSEC source: 0001213900-23-006191 · ownership.xml · derivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,975 Underlying: Common Stock · 6,975 shares Expires 2029-08-06 F1 · price: These securities were received on the closing date of the merger (the "Business Combination") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the "Merger Agreement"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) ("HSAC2"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation ("Legacy Orchestra"), in exchange for a nonstatutory stock option to acquire 15,000 shares of common stock of Legacy Orchestra Legacy Orchestra ("Legacy Orchestra Common Stock") for $2.00 per share. Read SEC document |
| January 26, 2023 Filed May 19, 2023 21:40 UTC Amendment | Orchestra BioMed Holdings, Inc. OBIO · Entity 434 | GrantNonstatutory Stock Option (Right to Buy) · Derivative | 18,228 | Not disclosed Strike: $10.00 | Not disclosed |
DisclosureSEC source: 0001213900-23-041615 · ownership.xml · derivative · entry 1 Aiello Joshua · CIK 0001960418 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,228 Underlying: Common Stock · 18,228 shares Expires 2032-08-17 F1 · security: On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently misstated the expiration date of one class of nonstatutory stock options ("NSOs"). In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to correct the incorrect expiration date in Table II, Column 6 to August 17, 2032; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing. F3 · price: Received in the Business Combination in exchange for a nonstatutory stock option to acquire 39,200 shares of Legacy Orchestra Common Stock for $4.65 per share. F2 · derivative.exercise_date: The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the day of the month of each quarter that is the same day of the month as the grant date, starting with the corresponding date in the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.